Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
161
Employees161
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
161
Employees161

LYEL Key Statistics

Market cap
264.41M
Market cap264.41M
Price-Earnings ratio
-0.92
Price-Earnings ratio-0.92
Dividend yield
Dividend yield
Average volume
108.11K
Average volume108.11K
High today
$10.98
High today$10.98
Low today
$10.46
Low today$10.46
Open price
$10.91
Open price$10.91
Volume
152.62K
Volume152.62K
52 Week high
$45.00
52 Week high$45.00
52 Week low
$10.46
52 Week low$10.46

Stock Snapshot

Lyell Immunopharma(LYEL) stock is priced at $10.78, giving the company a market capitalization of 264.41M. It carries a P/E multiple of -0.92.

On 2026-09-16, Lyell Immunopharma(LYEL) stock moved within a range of $10.46 to $10.98. With shares now at $10.78, the stock is trading +3.0% above its intraday low and -1.9% below the session's peak.

Trading activity shows a volume of 152.62K, compared to an average daily volume of 108.11K.

Over the past 52 weeks, Lyell Immunopharma(LYEL) stock has traded between a high of $45.00 and a low of $10.46.

Over the past 52 weeks, Lyell Immunopharma(LYEL) stock has traded between a high of $45.00 and a low of $10.46.

LYEL News

Investing.com 6d
H.C. Wainwright reiterates Lyell Immunopharma stock rating at buy - Investing.com

...

H.C. Wainwright reiterates Lyell Immunopharma stock rating at buy - Investing.com
TipRanks 6d
Lyell Immunopharma advances LYL273 CAR T program

Lyell Immunopharma ( (LYEL) ) has issued an update. On September 10, 2026, Lyell Immunopharma announced it had completed the technology transfer for its next-g...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
0%
Sell
12.5%

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.